Metasurfaces are two-dimensional (2D), nanoengineered surfaces that interact strongly with electromagnetic waves and can ...
NuCana PLC (NASDAQ: NCNA) gained 22.1% to $6.19 in pre-market trading. NuCana highlighted synergy between NUC-7738 and PD-1 inhibitors in RCC Organoids, supporting expansion of NuTide:701 clinical ...
Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by ...
The SHARON trial is ongoing and will be expanding to include patients without a BRCA or PALB2 mutation, and General Oncology plans to continue evaluating outcomes and long-term follow-up in this ...
Abstract: The terahertz (THz) waves have broad application prospects in communication, imaging, detection, and other fields. Achieving arbitrary control of THz waves is key to advancing THz technology ...
Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopeniaRecommendation based on LUNA 3 phase 3 study ...
A team from the Faculty of Physics and the Center for Quantum Optical Technologies at the University of Warsaw has developed ...
The field of cancer immunotherapy has gained significant attention as a promising therapeutic approach, especially in light ...
OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback